Exclusive: Advent’s healthcare investment platform mulls betting on south Indian API maker
Advent, one of the world’s biggest private equity players, is evaluating an investment in a Chennai-based active pharmaceutical ingredient (API) company through its pharma platform Cohance, three people aware of the development told VCCircle on condition of anonymity. The PE firm, which rebranded its API and CDMO platform to Cohance in ......
Exclusive: Blackstone, Carlyle, others eye controlling stake in Indian healthcare firm
Private equity behemoth Blackstone is among a clutch of bulge-bracket global investors who are in the race to pick up a controlling stake in an Indian healthcare company, three people aware of the development told VCCircle. Blackstone, which struck its first hospital deal in India last year and invested $1 billion to ......
Advent International looks to stitch secondaries deal to exit packaging firm
Global private equity firm Advent International, which is reportedly increasing its share of corpus to deploy in India for striking fresh bets, has hired bankers to help exit one of its portfolio firms through a secondaries deal, two people aware of the development told VCCircle. Advent International has been trying to ......
Grapevine: Carlyle-backed Hexaware taps i-banks for IPO; Mankind Pharma eyes Bharat Serum
US private equity giant Carlyle has assembled a syndicate of five investment banks to facilitate the forthcoming IPO of portfolio firm Hexaware Technologies, a media report said. The syndicate includes Kotak Mahindra Capital, Citi, JP Morgan, IIFL Capital, and HSBC Securities. The IPO is intended to offer Carlyle a partial ......
Searchlight: How a bootstrapped tour and travel firm stood its ground as peers struggled
India’s tour and travel services sector has gone through much disruption over the last decade with several companies folding up or merging with bigger competitors despite raising venture capital funding, but a handful of bootstrapped operators have managed to defy the odds. Mumbai-based Akbar Travels of India Pvt. Ltd is ......
Exclusive: Jashvik Capital, others in fray to bet on local medical device company
Growth stage private equity player Jashvik Capital, which was floated by former TA Associates executive Naresh Patwari, is among multiple other investors to pick up a stake in a homegrown surgical equipment player, at least two people aware of the development told VCCircle. Jashvik, an investor in snacks maker Jabsons, is ......
Grapevine: Advent may invest up to $10 bn in India; Mizuho to buy stake in lender
US-based private equity firm Advent International is looking at making investments of $5-10 billion in India over the next five years, a media report said. The firm, which has completed 17 investments totaling $5.8 billion since 2009, remains optimistic on India, despite concerns about high valuations, Advent International Chairman David Mussafer ......
Deals Digest: Weekly volume drops but total value jumps on large PE transaction
A large transaction in the healthcare sector and a couple of mid-sized transactions boosted the total value of private equity and venture capital deals this week to more than $400 million. Deal volume, however, dropped on a week-on-week basis, according to data collated by VCCircle. The week saw Indian companies securing around ......
Grapevine: Neuberg Diagnostics eyes pre-IPO funding; Tatas in talks for Fabindia stake
Neuberg Diagnostics, a super-specialty diagnostics chain, intends to raise about $100 million (Rs 835 crore) from private equity investors ahead of a planned initial public offering, a media report said. The company, backed by healthcare entrepreneur GSK Velu, has enlisted investment bank o3 Capital to secure the funding, Moneycontrol reported, ......
KKR-controlled JB Chemicals draws interest from PE firms, drugmakers
A clutch of suitors including pharmaceutical companies and bulge-bracket private equity firms have shown interest in picking up a majority stake in JB Chemicals & Pharmaceuticals Ltd, two people aware of the development told VCCircle. Mumbai-listed JB Chemicals is controlled by US-based buyout firm KKR & Co, which bought an almost ......
